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Summary Background. The irritant sodium lauryl sulfate (SLS) is known to cause a decrease
in the stratum corneum level of natural moisturizing factor (NMF), which in itself is
associated with changes in corneocyte surface topography.
Objective. To explore this phenomenon in allergic contact dermatitis.
Methods. Patch testing was performed on patients with previously positive patch test
reactions to potassium dichromate (Cr), nickel sulfate (Ni), methylchloroisothiazolinone
(MCI)/methylisothiazolinone (MI), or p-phenylenediamine. Moreover, a control (pet.)
patch and an irritant (SLS) patch were applied. After 3 days, the stratum corneum from
tested sites was collected, and NMF levels and corneocyte morphology, expressed as the
amount of circular nanosize objects, quantified according to the Dermal Texture Index
(DTI), were determined.
Results. Among allergens, only MCI/MI reduced NMF levels significantly, as did SLS.
Furthermore, only MCI/MI caused remarkable changes at the microscopic level; the cor-
neocytes were hexagonal-shaped with pronounced cell borders and a smoother surface.
The DTI was increased after SLS exposure but not after allergen exposure.
Conclusions. MCI/MI significantly decreased NMF levels, similarly to SLS. The altered
corneocytemorphology suggests that skin barrier damage plays a role in the pathogenesis
of MCI/MI contact allergy. The DTI seems to differentiate reactions to SLS from those to
the allergens tested, as SLS was the only agent that caused a DTI increase.
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Allergic contact dermatitis (ACD) and irritant contact
dermatitis (ICD) are common inflammatory skin diseases
that pose a major problem in public health because
of the widespread use of skin irritants and/or contact
allergens in occupational settings and in consumer prod-
ucts. Although these two forms of contact dermatitis
have different pathogenesis, they show similar clinical
features, including erythema, fissuring, and vesicles,
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and, in a more severe form, bullae (1, 2). The primary
step in the development of ICD is, for most skin irritants,
characterized by disruption of the skin barrier, which is
followed by activation of the innate immune systemwith-
out involvement of T cells (3). A genetic deficiency of the
epidermal protein profilaggrin is a strong predisposing
factor for ICD (4, 5). The odds ratio (OR) for filaggrin gene
(FLG) mutations, adjusted for atopic dermatitis (AD), was
1.61, whereas individuals with a history of AD who are
also carriers of an FLG mutation have a 4.7-fold risk for
ICD (6). A history of AD increases the risk for ICD three-
fold. It has to be noted, however, that AD patients without
FLG mutations also have reduced filaggrin expression
caused by T helper 2-mediated inflammation in AD (7).
Filaggrin and its degradation products, which are the
main constituents of natural moisturizing factor (NMF),
are responsible for a number of functions concerning
skin barrier function in the stratum corneum, including
mechanical properties, skin hydration, and the epidermal
inflammatory response (8). Recently, it has been shown
that various skin irritants significantly reduce the levels
of NMF (3). NMF levels, in turn, showed a strong associ-
ation with corneocyte surface morphology, expressed as
the Dermal Texture Index (DTI), supporting the view that
alterations in the skin barrier play amajor role in ICD (9).
The effect of contact allergens on the skin barrier has
not been extensively studied to date, and, if so, it has
been mainly assessed with skin bioengineering tech-
niques such as transepidermal water loss measurement
(10). However, skin barrier defects arising from con-
comitant irritant properties of an allergen may play an
important role in the activation of the adaptive immune
response and the development of ACD (10–13). ACD is
a type IV cell-mediated immune reaction, separated into
two distinct phases: the sensitization phase, in which the
immune system is primed to react to a given allergen [usu-
ally molecules with a molecular weight (MW) of <500],
and the elicitation phase, following re-exposure. In this
process, the impaired skin barrier may facilitate sensiti-
zation in the first place, but also the allergic response as
a result of the increased penetration of contact allergens
(8, 11, 12). The structural components of the stratum
corneum, such as the extracellular lipidmatrix, the corni-
fied envelope, and the corneodesmosomes, are primary
targets formost irritants (13). Recently, it has been shown
that the model irritant sodium lauryl sulfate (SLS) affects
the expression of filaggrin (14, 15). Similar morpho-
logical changes have also been seen in mice when they
are exposed to 2,4,6-trinitro-1-chlorobenzene, a potent
contact allergen (16). Studies on the effect of contact
allergens on corneocyte morphology in humans are
lacking. Therefore, in the present study, we investigated
the levels of NMF, the associated filaggrin-degradation
enzymes bleomycin hydrolase (BH) and calpain-1 (C-1)
and stratum corneum plasmin, as an indicator of skin
barrier damage and corneocyte surface topography and
morphology (9, 17, 18). We focused on the effects of
skin exposure to clinically relevant allergens: potassium
dichromate (Cr), nickel sulfate (Ni), methylchloroiso-
thiazolinone (MCI)/methylisothiazolinone (MI), and
p-phenylenediamine (PPD), and to themodel irritant SLS.
Methods
Patients
The database of the dermatological outpatient clinic of the
Zagreb University Hospital was screened for individuals
with positive patch reactions, clinically graded according
to the ESCD/ICDRG guidelines as 1+ or 2+, to one of
four common contact allergens: Cr, Ni, PPD, and MCI/MI
(19). Patients with two or more 1+ or 2+ reactions to Cr,
Ni, PPD or MCI/MI were preferred, as multiple allergens
could be tested in1 individual. Patientswith a3+ reaction
were not selected, to avoid severe reactions that might
impair tape stripping. Patients with a history of AD were
excluded. The experimental protocol followed the Dec-
laration of Helsinki Principles, and was approved by the
Medical Ethics Committee of the University Hospital Cen-
tre Zagreb. Written informed consent was obtained from
each participant.
Procedure
All participants were patch tested on the back with one
or two allergens to which the participant had previously
shown a 1+ or 2+ patch test reaction, and also with
SLS and pet. The tested substances were applied in van
der Bend chambers (van der Bend, Brielle, The Nether-
lands), namely, PPD 1% pet., potassium dichromate 0.5%
pet. (Almirall Hermal, Reinbeck, Germany), nickel sulfate
5% pet., and MCI/MI 3:1 in 0.01% aq. (Smartpractice
Europe, Barsbüttel, Germany). To provoke ICD, patches
with 1% and 2% SLS aq. were used. A patch with the
vehicle (100% pet.) was used as a control. Four identi-
cal patch series were applied: two series on the left and
two series on right side of the upper back. Two identical
series on the left sidewereused for respective day (D) 2 and
D3 assessment, enabling stripping on ‘fresh’ non-stripped
skin sites. The patches on the right side of the back func-
tioned as a back-up for possible technical failures. On D2,
all patches were removed, patch sites were marked, and
the skin was allowed to rest for 30min. On D2 and D3,
respectively, the stratum corneum samples from the skin
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sites where the duplicate patches had been applied were
collected with adhesive tape (1.5 cm2, D-Squame; CuD-
erm,Dallas, TX,USA) (20). In total, eight consecutive tape
stripswere taken fromeachpatchapplication site for anal-
ysis. Different tapes were used for the various analyses;
tape 3 was used for atomic force microscopy (AFM), tape
4 for proteases, and scanning electronmicroscopy (SEM),
and tape 5 for NMF analysis.
NMF and protease activity
NMF was defined as the sum of the concentrations of
pyrrolidone carboxylic acid, urocanic acid, and histidine.
NMF levels were determined according to a method
described in detail elsewhere (21). Briefly, the fifth
tape strip was extracted with 0.5ml of 25% ammonia.
The ammonia extract was evaporated and the residue
was dissolved in 250 μl of water before analysis by
high-performance liquid chromatography (HPLC). The
NMF level was normalized for the stratum corneum
protein amount determined with a Pierce Micro BCA
protein assay kit (Thermo Fisher Scientific, Rockford,
IL, USA) to compensate for the variable amount of the
stratum corneum protein on the tape strips. Enzymatic
activities of BH, C-1 and plasmin were determined in
eight randomly selected subjects who were positive either
for Ni or MCI/MI and their corresponding unpatched
and pet. test sites. The analysis has previously been
described in detail by Raj et al. and Voegeli et al. (17,
22–25). Briefly, buffer extracts of the tape strips (250 μl)
were combined with fluorogenic peptide substrates
(1.25 μl) (for BH-like activity, H-Cit-AMC; for C-1-like
activity, Suc-Leu-Leu-Val-Tyr-AMC; and for plasmin-like
activity, MeOSuc-Ala-Phe-Lys-AMC), and agitated at
1000 rpm at 37∘C. The reaction was stopped after 2 h
by adding acetic acid (250 μl). The released AMC was
quantified by reverse-phase HPLC (excitation at 354nm;
emission at 442nm), and the results were corrected
for stratum corneum protein content on the tape strips
as determined with the 850-nm absorption infrared
densitometer SquameScan 850A (Heiland Electronic,
Wetzlar, Germany), according to a procedure described
elsewhere (24).
Corneocyte morphology
Corneocytes from patients were analysed by AFM as
described by Franz et al. (26). Briefly, the third consec-
utive tape strip was subjected to AFM measurements
carried out with a Multimode atomic force micro-
scope equipped with a Nanoscope III controller and
software version 5.30sr3 (Digital Instruments, Santa
Barbara, CA, USA). Silicon nitride tips on V-shaped
gold-coated cantilevers were used (0.01N/m, MLCT;
Veeco, Mannheim, Germany). Imaging was performed at
ambient temperature with forces less than 1nN at one
to three scan lines per second (1–3Hz) with a resolution
of 512×512 pixels. For texture analysis, subcellular
scan areas of 20×20 μm2 were recorded. For a larger
overview, images of 70×70 μm2 were recorded. Topo-
graphical data of the corneocyte surfaces were analysed
with the nAnostic™ method, by the use of custom-built,
proprietary algorithms (Serend-ip, Münster, Germany).
The method evaluates each nanostructure protruding
from the mean surface level, referred to as circular
nanosize objects (CNOs). These are then automatically
filtered according to their size and shape; in the present
study, only structures of positive local deviational vol-
ume smaller than 500nm in height and with an area of
<1 μm2 are considered. The DTI counts these features
for an area of 20×20 μm2 of cell surface per image (9).
For MCI/MI and SLS, SEM was performed on the tape
strips from 1 person. Fragments of D-Squame tapes were
observed at a partial vacuum (0.133 kPa) without prior
preparation of the samples (native state). Images of the
removed corneocyte layers were recorded at 15 kV with
the secondary electron detector of a Quanta 250 FEI
scanning electron microscope.
Statistics
Data analysis was performed with GRAPHPAD PRISM®
version 6.07 (GraphPad Software, La Jolla, CA, USA).
Comparison of the NMF levels between different skin sites
(allergen/irritant/unpatched) and their corresponding
pet. controls in the same individual was performed with
a paired two-tailed t-test. Comparison of the activity of
BH, C-1 and plasmin between allergens and their pet.
controls was performed with the Wilcoxon signed rank
test if the distribution of data deviated from normal
distribution as tested by the Shapiro–Wilk test, and
with a two-tailed t-test when the data were normally
distributed. The Spearman correlation coefficient was
used to correlate the individual activities of the proteases
with NMF levels. The Pearson correlation coefficient was
used to correlate the individual patch test results (1+,
2+, and 3+) with NMF levels. One-way ANOVA followed by
Dunnett’s multiple comparison post hoc test was applied
to the differences in DTI between SLS and individual
allergens, pet., and unpatched skin sites. Data are shown
as the mean value and standard deviation (SD) when
distributed normally, and as median with interquartile
range when non-normally distributed.
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Fig. 1. The difference in the natural moisturizing factor levels
(ΔNMF) between the skin sites tested with potassium dichromate
(Cr), nickel sulfate (Ni), methylchloroisothiazolinone
(MCI)/methylisothiazolinone (MI) or p-phenylenediamine (PPD),
sodium lauryl sulfate (SLS), unpatched skin and their
corresponding pet. controls on day 3. The individual patch test
readings for each allergen are inserted as a table. As some patients
had positive reactions to two allergens, the number of reactions
(n=34) is greater than the number of patients (n=27). TheΔNMF
of a positive reaction is indicated by a circle symbol, and that of a
non-responder is indicated by a ‘X’ symbol. Non-responders were
excluded from data analysis. The results are shown as mean of all
subjects and standard deviation. The data of allergens, SLS and
unpatched skin were compared with those of their corresponding
pet. patches by use of a paired, two-tailed t-test. **p<0.01;
****p<0.0001.
Results
Clinical response
We included 27 patients (24 females), with an average
age of 49.3 years (SD 12.6). A total of 34 positive 1+
or 2+, 3+ reactions to the investigated allergens were
observed onD3: 11 forNi, 11 for Cr, eight forMCI/MI, and
four for PPD. Eleven patients had two positive reactions.
Although selection was based on 1+ or 2+ reactions,
several patients in thepresent studyhad3+ reactions (one
for Ni and Cr, and two for PPD). The clinical scores per
allergen per patient are shown in Fig. 1
Four patients, 1 for each allergen, did not show a posi-
tive reaction to the allergen to which they had had a pos-
itive reaction in the past. Furthermore, 1 patient had a
severe reaction to PPD, and the tape strip samples could
not be obtained. These patients (n=5) were excluded
from the data analysis.
NMF
Figure 1 shows the difference in the NMF levels (ΔNMF)
between the allergens, SLS, unpatched sites, and their
corresponding controls (pet.) on D3. A significant dif-
ference from the corresponding controls was observed
for SLS (1% and 2%) and MCI/MI. The smallest effect
was observed for Ni, for which none of the patients had
ΔNMF lower than the median response after MCI/MI
and SLS (Fig. 1). Although the difference with respect
to the pet. control did not reach statistical significance
for other allergens, several patients had negative ΔNMF
values. For example, 3 patients for Ni and 1 for Cr and
PPD showed NMF level decreases similar to the aver-
age decrease observed after MCI/MI and SLS (Fig. 1).
Interestingly, those 5 patients had strong patch test
reactions (3+ for Ni and Cr, and 2+ for PPD). To further
explore possible associations between patch test readings
and changes in NMF levels, we compared ΔNMF and
patch test readings. The Pearson correlation coefficient
amounted to −0.64 (p<0.001), indicating a significant
negative association between patch test reactions and
decrease in NMF levels. The NMF levels after D2, deter-
mined in a limited number of patients, showed the same
trend (data not shown). In each allergen group, 1 patient
had no reaction to the allergen (denoted in Fig. 1. by an
X symbol). As is evident from Fig. 1, the ΔNMF values
in these subjects were close to those for the pet. control.
There was no significant difference in the NMF levels
between skin sites where no patches were applied and
sites with pet.
Corneocyte surface morphology
The DTI values were determined from the AFM images of
a 20×20-μm2 area. As shown in Fig. 2, among all inves-
tigated compounds, only SLS led to a significant rise in
the DTI, indicating increased numbers of CNOs, which
can clearly be seen from Fig. 3g, representing a more
detailed 20×20-μm2 image of an SLS-tested skin site.
The CNOs in the SLS image were also shown by SEM
(Fig. 4). Larger overview AFM images (70×70 μm2) of
the corneocytes from the skin sites testedwith Cr, Ni, PPD,
MCI/MI, SLS and pet. are shown in Fig. 3a–f. The images
show that, at a microscopic level, the results for Cr, Ni
and PPD resemble those for pet. MCI/MI differed, in that
it caused distinct alterations in the structure; corneocytes
were hexagonal-shaped and had pronounced cell borders
(Fig. 3d). The surfaces were smoother, with a loss of cor-
neocyte surface microtexture. This was also confirmed by
SEM images showing loose lateral associations between
the cells from the MCI/MI-treated skin sites (Fig. 4). As
indicated in Fig. 2, these microscopic alterations did not
lead to an increase in cell surface CNOs; the average DTI
value from MCI/MI samples was similar to that for other
allergens and pet.
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Fig. 2. The Dermal Texture Index (DTI; number of circular
nanosize objects per 20-μm2 area) measured in the stratum
corneum collected on day 3. The results are averaged for all
subjects, and are shown as mean values and standard deviation.
The number of tested sites per group differed: Cr, n=3; Ni, n=5;
methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI),
n=4; p-phenylenediamine (PPD), n=3; sodium lauryl sulfate
(SLS), n=6; pet., n=7; and unpatched, n=4. The DTI values of
allergens/pet./unpatched skin were compared with those of the SLS
group; asterisks indicate level of significance. **p<0.01 (one-way
ANOVA followed by Dunnett’s multiple comparisons test).
Activities of stratum corneum BH, C-1, and plasmin
To explore whether allergens and SLS affect the activity
of proteases that are involved in the degradation of NMF,
we determined the activities of BH and C-1 in a limited
number of samples. Furthermore, we included plasmin
as an indicator of skin barrier damage. The activities of
BH, C-1 and plasmin (Fig. 5a–c) were significantly higher
in SLS-treated skin than in the corresponding pet. con-
trols (BH, p<0.01; C-1, p<0.05; and plasmin, p<0.01).
The allergens did not produce significant differences from
the pet. controls, although MCI/MI showed a trend of
increasing values for all three proteases (each p=0.13).
The activities of all three proteases were negatively cor-
related with corresponding NMF levels. The respective
Spearman correlation coefficients for BH, C-1 and plas-
min amounted to−0.52 (p<0.01),−0.47 (p<0.01), and
−0.58 (p<0.001).
Discussion
In the present study, we observed different effects of
contact allergens and SLS on relevant properties of the
epidermal barrier: the stratum corneum NMF levels,
corneocyte surface morphology, and stratum corneum
protease activities. NMF levels have previously been used
as a skin barrier biomarker in AD and ICD. To the best of
our knowledge, this is the first time that NMF levels have
been investigated in ACD (27, 28). Recent experimental
studies showed that skin irritants with different physic-
ochemical properties, such as SLS, NaOH, fruit acids
and aliphatic alcohols, significantly decrease the stratum
corneum NMF levels (28, 29). This is in accordance with
the findings from the present study, which show a signif-
icant reduction in NMF levels after exposure to 1% and
2% SLS. SLSmay potentially affect NMF levels in different
ways. As an alkaline compound, SLS may lead to an
increase in the stratum corneum pH, which might affect
the activity of stratum corneum proteases, including
those involved in filaggrin degradation into NMF compo-
nents. To explore this possibility,wemeasured, in a limited
number of samples, the activity of the stratum corneum
proteases BHandC-1, both ofwhich known to be involved
in breaking down filaggrin protein (30). The results sug-
gest that it is unlikely that the decrease in NMF levels
after SLS and MCI/MI treatment is caused by reduced
activity of these enzymes, as their activities showed an
opposite trend; protease activities were increased after
SLS treatment, and an increasing trend was observed for
MCI/MI (p=0.07). The activities of these proteases were
negatively correlated with NMF levels, so the increased
activity might be a feedback reaction to the reduced NMF
levels. SLS is known to denature proteins of the cornified
envelope, which may lead to the leakage of NMF compo-
nents from the corneocytes (31). This could also occur for
the proteases, causing better extraction from the corneo-
cytes and/or intercellular lipids. As the cornified envelope
acts as an attachment point for the intercellular lipids,
disruption of the cornified envelope additionally affects
skin barrier function (32, 33). Further evidence that the
reduction in NMF levels may be caused by skin barrier
damage is provided by increased plasmin activity follow-
ing SLS treatment (p<0.01), which indicates a damaged
skin barrier (18). A trend of increasing plasmin activity
was also observed after MCI/MI treatment (p=0.13).
Among the tested allergens, only MCI/MI caused a
significant reduction in NMF levels. It is not likely that the
NMF decrease after MCI/MI treatment is attributable to
downregulation of (pro)filaggrin, as the stratumcorneum
samples originate from the upper part of the stratum
corneum (approximately to the upper third of the stratum
corneum depth). The deeper stratum corneum layers
containing potentially downregulated expression of filag-
grin would require a further 14 days to reach the more
superficial part of the stratum corneum from which the
samples originated (34). As NMF is mainly located within
the corneocyte, where filaggrin degradation occurs, it
might be speculated that MCI/MI, like SLS, damages the
cornified envelope, resulting in leakage of NMF. MCI (the
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Cr (70µm × 70µm) 
a b c
d e
g
f
Ni (70µm × 70µm) PPD (70µm × 70µm)
MCI/MI (70µm × 70µm) SLS (70µm × 70µm) petrolatum (70µm × 70µm) 
SLS (close-up, 20µm × 20µm)  
Fig. 3. (a–g) Atomic force microscopy images from stratum corneum samples collected on day 3. (a) Chromium. (b) Nickel. (c)
p-Phenylenediamine. (d) Methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI). (e) Sodium lauryl sulfate (SLS). (f) Pet. (g) SLS,
close-up. Images are three-dimensional representations; the brightness corresponds to the height of the imaged structures. At the microscale
(70×70 μm2), distinct morphological changes are seen for MCI/MI and SLS. On a close-up view of an SLS sample (20×20 μm2) (g), circular
nanosize objects can be distinguished on the corneocyte surface.
most abundant component in the 3:1 MCI/MI mixture)
is a small lipophilic compound with favourable physico-
chemical properties for percutaneous penetration across
the membrane (Kow =2.5; MW 111). It has been shown
that MCI has corrosive properties and is retained in the
epidermis, probably because of binding to the epidermal
proteins (35, 36). In the present study, MCI/MI treatment
resulted in dramatic changes in the microscale corneo-
cyte structure, characterized by the smoother corneocyte
surfaces, the hexagonal shape, pronounced cell borders,
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Fig. 4. Scanning electron microscopy images of corneocytes on day 3 after application of pet. (a), methylchloroisothiazolinone
(MCI)/methylisothiazolinone (MI) (b) and sodium lauryl sulfate (SLS) at ×1350magnification. Note a loose lateral association between the
cells for the MCI/MI and the SLS test sites. Furthermore, circular nanosize objects can be distinguished on the corneocyte surface of the SLS
test site.
Fig. 5. Activities of bleomycin hydrolase (a), calpain-1 (b) and plasmin (c) in the stratum corneum samples of the skin sites tested with Ni
(n=4), methylchloroisothiazolinone (MCI)/methylisothiazolinone (MI) (n=4), sodium lauryl sulfate (SLS) (n=8) and their corresponding
pet. controls (n=8) and unpatched test sites (n=8). Data for bleomycin hydrolase are shown as median with interquartile range; those for
calpain-1 (b) and plasmin (c) are shown as mean± standard deviation. *p<0.05, **p<0.01; (a) Wilcoxon signed rank test; (b, c), paired
two-sided t-test).
and the absence of apparent fibrous structures, that were
distinctly different from the effects of the other three
allergens. As recently reviewed by Weidinger and Novak,
a compromised barrier may facilitate sensitization and
increased penetration of contact allergens (37). Inmurine
studies, the irritant effect of an allergen was shown to
determine the strength of the contact hypersensitivity
response (11). The decrease in NMF levels observed in
this study might at least partly have been caused by
irritant characteristics of MCI/MI, and this is perhaps an
explanation for its high allergenic potency. Although Ni
and Cr did not lead to significant changes in NMF levels,
individuals with the highest clinical scoring showed
the lowest NMF levels, suggesting that allergen-induced
inflammation and decreases in NMF levels are associated.
At the topographical scale, quantified by the num-
ber of CNOs (expressed as the DTI), MCI/MI did not
differ from the other allergens, and SLS was the only
substance showing increased DTI values. Increases in
DTI have recently also been found for other skin irri-
tants, such as NaOH and lactic acid (C. Riethmuller,
et al. pers. comm. 2016), suggesting that an elevated
DTI is characteristic of skin irritation. The mecha-
nisms that underlie the development of CNOs are not
yet clear. In another study by Riethmuller et al., AD
patients with compound heterozygote or homozy-
gote loss-of-function mutations in the filaggrin gene
were shown to have increased numbers of CNOs (9).
These patients lack filaggrin, which aggregates keratin
filaments within the corneocyte and is also present in the
cornified envelope. It might be suggested that, owing to
the lack of filaggrin, the cornified envelope is more fragile
and becomes more prone to structural changes resulting
from osmotic pressure within the corneocytes caused
by reduced NMF levels. Interestingly, this study shows
that allergen-induced inflammation does not result in
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the formation of CNOs, regardless of the low NMF levels,
indicating that their formation is multifactorial.
If the finding that the DTI does not change in ACD,
as we show for four clinically relevant allergens, can be
generalized to other allergens, the DTI might aid in dif-
ferentiating ACD from ICD. However, it has to be noted
that, in the occupational setting, mixed exposure to aller-
gens and skin irritants is common, so resultsmight be less
clear than in this controlled study. Moreover, many aller-
gens have irritant properties, so an increasedDTI does not
necessarily exclude ACD. Nevertheless, the investigated
parameters can provide more insights in the aetiology of
ICD andAD and the intrinsic irritant properties of contact
allergens, whichmight support more targeted prevention
in occupational settings.
Conclusion
Skin barrier characteristics, for example NMF levels and
the number of nanosize objects (DTI) on the corneocyte
surface, are useful for studying the effects of skin irritants
and contact sensitizers on the epidermis. In contrast to
the other allergens investigated, MCI/MI showed distinct
effects on the skin barrier in termsof a significant decrease
in NMF levels, similarly to SLS, and MCI/MI also had
profound effects on corneocyte morphology; collectively,
these findings suggest that skin barrier damage plays a
role in the pathogenesis of MCI/MI contact allergy. The
DTI seems to differentiate reactions to the tested allergens
and to SLS, as the latter was the only agent that caused an
increase in theDTI.Whether the effects onNMF levels and
the DTI can be generalized to other skin irritants should
be confirmed in further studies including irritants with
different physicochemical properties.
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